drugset
drugset / Trial / NCT00561223

Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)

NCT00561223 ↗

Completed 10 enrolled University of Oklahoma
NaSingle-groupOpen-labelTreatment

Summary

The investigators believe that iloprost will improve gas exchange in COPD patients with pulmonary hypertension.

Timeline

Start
2006-11
Primary completion
2008-04
Completion
2012-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 2.5 mg Inhaled

Indications

chronic obstructive pulmonary disease pulmonary hypertension